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Long-term prognosis of patients 
with paediatric-onset infl ammatory bowel 
disease after transfer to adult care 
– a retrospective observational study
Tena Trbojević1, Lea Miklić1, Lana Ivković1, Filip Simon1, Iva Hojsak1,2,3, Sanja Kolaček1,2
Aim: The aim of this study was to evaluate and report long-term prognosis of infl ammatory bowel disease (IBD) in patients 
transferred to adult care.
Methods: We reviewed medical records of all patients treated in our tertiary medical centre and then on adult care for a minimum 
of 5 years (median 12.4 years).
Results: During the study period, 52 IBD patients were treated in our centre and 27 patients/families were available for interview 
(13 of them women; median age 29 years; 20 with Crohn’s disease and 7 with ulcerative colitis (UC)). Twenty-three (85%) patients 
were transferred to adult care, whereas 4 (15%, 3 with UC) patients never consulted an adult gastroenterologist. Nineteen (70%) 
patients experienced a relapse, 2 (7.4%) died, and 9 (33%) received biological therapy in adult care. Of the surviving patients, 8 (32%) 
underwent surgery in adult age.
Conclusion: This study confi rmed that, in the absence of organized transition to adult care, a number of patients would never 
transfer on their own, causing discontinuity of care.
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INTRODUCTION
In 25%-30% of all patients, infl ammatory bowel disease (IBD) 
(Crohn’s disease (CD), ulcerative colitis (UC), and IBD-unclas-
sifi ed (IBD-U)) is diagnosed during childhood or adoles-
cence (1). Compared to adult-onset disease, the phenotype 
of paediatric-onset IBD signifi cantly diff ers and is marked by 
increased severity, more extensive distribution, further 
worsening within the fi rst two years of the diagnosis, and 
higher need for surgical treatment (2, 3). Therefore, it is rea-
sonable to expect the long-term outcome to diff er as well, 
but relevant data are limited and controversial (4-6).
This survey aimed to provide data on long-term outcomes 
(relapse rate, mortality rate, and therapy escalation) in pae-
diatric-onset IBD patients, reported at least fi ve years after 
they had been transferred from our tertiary paediatric med-
ical centre to adult care, as well as to assess their transfer 
experience.
METHODS
Study design. This was a retrospective, single-centre, ob-
servational study with survey analysis. Clinical data on all 
patients diagnosed with IBD in our tertiary medical centre 
from 1993 to 2003 were analysed retrospectively, provid-
ed there was a follow-up of at least fi ve years after their 
transfer to adult care. Patients were transferred at the age of 
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18 years or after graduating from high school. Data were 
obtained from hospital charts and electronic medical re-
cord system.
Patients were contacted and interviewed by phone in re-
spect to the following data: current primary care practitio-
ner, responsible adult gastroenterologist (GI), therapeutic 
interventions (surgery, current and previous therapy) re-
ceived, number of relapses in adult care, and adherence to 
medication. The phone interview also included a short sur-
vey about the patient’s satisfaction with the care provided 
in the paediatric and adult settings.
The study was conducted in accordance with ethical stan-
dards set by the institutional Ethics Committee regarding 
human experimentation and approved by the Ethics Com-
mittee of the Zagreb Children’s Hospital (doc. no. 01082015), 
as well as in compliance with the Helsinki Declaration.
IBD = infl ammatory bowel, CD = Crohn’s disease, UC = ulcerative colitis
FIGURE 1. Study fl owchart.
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Objectives. The primary objective was to determine long-
term prognosis (self-reported relapse rate, mortality rate, 
and therapy escalation) of patients with paediatric-onset 
IBD after transfer from the paediatric setting. Relapse was 
defi ned as the need of induction therapy (corticosteroids) 
or escalation of the maintenance treatment. The secondary 
objective was to assess transfer experience through a short 
survey.
Data analysis and statistics. Results are presented as num-
bers and percentages for categorical variables and as me-
dian and range for continuous variables due to their non-
normal distribution. Univariate regression was used to eval-
uate the association between age at diagnosis, disease 
distribution at diagnosis, and outcomes (need for escalation 
of therapy and need for surgery). Statistical analyses were 
performed using SPSS 21.0 (Chicago, IL). The level of statisti-
cal signifi cance was set at p<0.05.
RESULTS
Patients. A total of 52 patients were eligible for inclusion in 
the study (Figure 1), out of whom 28 (54%) patients or their 
families could be reached. One patient refused to partici-
pate. Thus 27 patients were available for the study, 20 (74%) 
with CD and seven (26%) with UC. Thirteen (48%) of them 
were females, median age 29 (range 24-40) years at the time 
of the interview, whereas the median age at diagnosis was 
12.5 (range 4.5-18) years. One-third of the patients (8 of 27) 
were diagnosed with IBD before the age of ten years. Pa-
tients had been treated in the paediatric facility for a medi-
an of 3.9 (1-14.6) years and in an adult setting for a median 
of 12.4 (range 5.8-23.0) years at the time of the interview. 
The median disease duration was 17.2 (12.9-24.8) years.
Primary outcomes. Four (15%) patients, one with CD and 
three with UC, never consulted a GI specialist. Of the non-
transferred patients, the one with CD was followed up by a 
general practitioner, whereas three patients with UC were 
not followed-up at all and received no therapy.
Of the patients who did undergo further GI follow-up 
(n=23), 19 (83%) had at least one relapse after transfer to 
adult care, and four (17.3%) were in sustainable clinical re-
mission with a median follow-up of 12.4 years.
Of the patients with disease relapse (n=19, 70%), 16 had 
more than two relapses resulting in a treatment step-up. 
Biological therapy was introduced in nine (33%) patients. 
Two (7.4%) patients died, both followed up by a GI special-
ist. The disease distribution is illustrated in Figure 1.
Of the surviving patients (n=25), eight (32%) underwent 
surgery in adult age (all CD patients); six patients had al-
ready undergone surgery in paediatric age.
Nine (33%) patients (fi ve with CD and four with UC) discon-
tinued their therapy on their own, which resulted in severe 
relapses in four patients (two with UC and CD each) and 
required escalation of therapy.
At the time of the survey, 7/27 (26%) patients (four with UC 
and three with CD) were in remission and without any med-
ication. Of these patients, four (three with UC and one with 
CD) had stopped using their medication on their own and 
were not followed up by a GI (median time of self-reported 
remission was 12.4 years); of the other three transferred pa-
tients, one CD patient had stopped using his medication on 
his own and two patients (one with UC and CD each) were 
advised so by their gastroenterologist because of stable re-
mission.
Univariate regression yielded no signifi cant association of 
age at diagnosis and disease distribution at diagnosis with 
the outcomes (need for escalation of therapy and need for 
surgery).
Secondary outcome – transfer experience. Of the transferred 
and interviewed patients (n=21), 13 (62%) described leav-
ing the paediatric care as stressful, and 16 (76%) preferred 
the paediatric setting for the following reasons: diagnostic 
procedures and doctor’s appointments were off ered at 
much shorter intervals (n=7), doctor-patient communica-
tion (n=3), as well as the general environment (n=3) were 
better in the paediatric facility, and no death of another pa-
tient was witnessed, which was the case in adult facilities 
(n=3). Only one patient preferred the adult setting because 
of direct patient-doctor communication without parents’ 
interference.
DISCUSSION
This study assessed long-term outcomes in paediatric-
-onset IBD patients with long-term follow-up (median 12.4 
years). The transfers were performed without a special (or-
ganized) transition process. Most of our patients (23/27; 
85%) continued receiving regular care in the adult setting, 
which is in concordance with the results of other studies (7, 
8). Furthermore, our study showed that seven (26%) pa-
tients were in long-term medication-free remission.
Our study confi rmed a high relapse rate (70%) and disease 
complications in the transferred patients. Furthermore, one-
third of the patients (all with CD) underwent surgery; how-
ever, the majority of them had their fi rst surgery in paediat-
ric age. This is in line with previous publications reporting a 
cumulative risk of resection of 26% during a median follow-
up of 9.1 years in paediatric-onset CD (5). The actuarial risk 
of having an extensive intestinal resection at the age of 30 
years was estimated to be approximately 50% (9). The cu-
72
TRBOJEVIĆ T., MIKLIĆ L., IVKOVIĆ L., ET AL. LONG-TERM OUTCOME IN PAEDIATRIC-ONSET IBD. PAEDIATR CROAT. 2018;62:69-73
mulative risk of exacerbation and step-up to biological ther-
apy during follow-up (follow-up of 9.1 years) in the patients 
with paediatric-onset CD was 66% and 54%, respectively, 
whereas in the patients with paediatric-onset UC (follow-up 
of 8.5 years) it was 84% and 34%, respectively (5). The risk 
was somewhat lower in our patients (33%). However, our 
study included both CD and UC patients.
None of our study patients developed cancer, and two pa-
tients with CD died due to disease complications. Both 
were under adult GI care at that time. In one case, the cause 
of death was fulminant sepsis at the age of 31 years, and in 
the other, at age 29, liver transplant failure complicated with 
sepsis in a CD patient with Budd-Chiari syndrome.
Complicated behaviour at diagnosis of CD predicted worse 
long-term outcomes and was associated with an increased 
risk of surgery, but not with the risk of fl are or step-up to 
biological therapy. In patients with UC, severe disease at di-
agnosis, but not disease extent, was associated with the risk 
of colectomy, fl are, and biological therapy (5). Our study 
found that neither the disease extent in CD or UC nor the 
age at diagnosis was associated with a higher number of 
relapses or an increased risk of surgery.
We also found that nine (33%) patients ceased therapy on 
their own after leaving the paediatric care, four of which ex-
perienced severe relapses. This percentage is higher com-
pared to the results of Sewitch et al., who report discontinu-
ing medication in 19% of IBD patients (10). However, our 
study involved a much longer follow-up time, which could 
partially explain this diff erence.
Switching from the paediatric to the adult healthcare sys-
tem is both emotionally stressful and challenging for pa-
tients, their families, and physicians (11). This was also con-
fi rmed by our results, as 62% of our patients described the 
experience of the transfer as stressful. Moreover, 76% of 
them preferred the paediatric care setting for the reasons 
reported above, such as a friendlier and more patient-ori-
ented environment and less time spent waiting for diagnos-
tic and therapeutic consultations (7, 11). Signifi cant limita-
tions of the immediate transfer (11) and the need for 
smooth transition from paediatric to adult care resulted in 
the organization of transition clinics worldwide where orga-
nized transition (transitional care) is provided by paediatri-
cians and internal medicine specialists for a defined period 
of time (12-14). Unfortunately, our patient cohort did not 
experience a smooth transition process, and it would be of 
interest to investigate whether our patients would have had 
better outcomes if they had been transferred through tran-
sition clinics.
There were signifi cant limitations to our study; the number of 
recruited patients was small, a considerable number of them 
could not be reached, and all patients had received paediat-
ric care in the same centre. Furthermore, the study was retro-
spective and therefore prone to recall bias. However, as the 
follow-up was exceptionally extended, we believe that this 
survey contributes to better understanding the long-term 
outcomes in patients with paediatric-onset IBD.
This study confi rmed that in the absence of organized tran-
sition to adult care, a number of patients would never trans-
fer on their own, thus causing discontinuity of care and re-
ceiving no cancer surveillance.
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S A Ž E T A K
Dugoročna prognoza u oboljelih od kroničnih 
upalnih bolesti crijeva dijagnosticiranih u dječjoj dobi 
nakon prelaska u zdravstvenu skrb odraslih 
– retrospektivna opservacijska studija
Tena Trbojević, Lea Miklić, Lana Ivković, Filip Simon, Iva Hojsak, Sanja Kolaček
Cilj: Cilj je ove studije procijeniti i izvijestiti o dugoročnoj prognozi u bolesnika s kroničnim upalnim bolestima crijeva (IBD), koji su 
nastavili liječenje u zdravstvenoj skrbi odraslih.
Metode: Pregledali smo bolesničku medicinsku dokumenaciju svih bolesnika koji su liječeni u tercijarnom pedijatrijskom medi-
cinskom centru i koji su barem pet godina nastavili liječenje u adultnoj skrbi (medijan 12,4 godina).
Rezultati: U razdoblju od 1993.-2003. u našem je centru liječeno 52-je bolesnika s IBD-om te su oni ili njihove obitelji bili dostupni za 
razgovor (13 žena, medijan dobi 29 godina; 20-ero oboljelih od Crohnove bolesti, sedmero od ulceroznog kolitisa (UC)). Ukupno je 
23-je (85%) bolesnika nastavilo liječenje u internističkoj skrbi, dok njih četvero (15%) nikad nije bilo ni na jednom pregledu internista 
gastroenterologa (troje bolesnika oboljelo od UC). Ukupno je 19-ero (70%) bolesnika imalo relaps tijekom praćenja, dvoje (7,4%) 
bolesnika je umrlo, devetero (33%) je primilo biološku terapiju. Trećina bolesnika je kirurški liječena u odrasloj dobi.
Zaključak: Ova studija potvrđuje važnost organizirane tranzicije iz pedijatrijske skrbi u zdravstvenu skrb odraslih.
Ključne riječi: kronične upalne bolesti crijeva, dugoročna prognoza, prijelaz skrbi, transfer, tranzicija
